Finance

Lists
Why is 300511 down 2,33%?
Dive Deeper
300511:SHE
Shanghai Xuerong Biotechnology Co Ltd
4,61 CN¥
-2,33%
(-0,11) 1D
15-окт., 10:56:31 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300511...
Open
4,62 CN¥
High
4,66 CN¥
Low
4,58 CN¥
Mkt. cap
3,08 млд
Avg. vol.
36,04 млн
Volume
7,46 млн
P/E ratio
20,30
52-wk high
8,50 CN¥
52-wk low
4,58 CN¥
EPS
0,23 CN¥
Shares outstanding
640,85 млн
No. of employees
2 миң
Open
4,62 CN¥
High
4,66 CN¥
Low
4,58 CN¥
Mkt. cap
3,08 млд
Avg. vol.
36,04 млн
Volume
7,46 млн
P/E ratio
20,30
52-wk high
8,50 CN¥
52-wk low
4,58 CN¥
EPS
0,23 CN¥
Shares outstanding
640,85 млн
No. of employees
2 миң
News stories
From web sources and news partners
The Daily News | Texas' Oldest Newspaper
The Daily News | Texas' Oldest Newspaper
·
27 мүнөт мурун
FILE PHOTO: SK Hynix at the Nasdaq market in New York
Yardeni QuickTakes
Yardeni QuickTakes
·
3 мүнөт мурун
Continue To Proceed With Caution
The Globe and Mail
The Globe and Mail
·
45 мүнөт мурун
U.S. Analyst Updates: October 14th, 2026
About Shanghai Xuerong Biotechnology Co Ltd
CEO-
Employees1,92 миң
Founded1995
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
534,26 млн
662,68 млн
678,92 млн
477,38 млн
Cost of goods sold
445,16 млн
506,32 млн
450,58 млн
577,16 млн
Cost of revenue
445,16 млн
506,32 млн
450,58 млн
577,16 млн
Research and development expenses
634,55 миң
976,13 миң
776,37 миң
1,23 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
36,26 млн
43,50 млн
34,05 млн
47,05 млн
Operating expense
42,33 млн
50,47 млн
39,79 млн
53,55 млн
Total operating expenses
487,49 млн
556,79 млн
490,37 млн
630,71 млн
Operating income
46,77 млн
105,89 млн
188,55 млн
-153,34 млн
Other non operating income
-151,07 миң
-425,46 миң
-5,97 млн
5,90 млн
EBT including unusual items
41,82 млн
94,64 млн
175,70 млн
-161,76 млн
EBT excluding unusual items
36,34 млн
93,84 млн
173,35 млн
-165,94 млн
Income tax expense
756,94 миң
15,39 миң
48,31 миң
163,44 миң
Effective tax rate
1,81%
0,02%
0,03%
-0,10%
Other operating expenses
5,19 млн
5,48 млн
5,15 млн
4,93 млн
Net income
40,20 млн
92,14 млн
173,17 млн
-155,32 млн
Net profit margin
7,53%
13,90%
25,51%
-32,54%
Earnings per share
-
-
-
-
Interest and investment income
-
380,11 миң
196,43 миң
1,10 млн
Interest expense
-10,04 млн
-16,04 млн
-9,42 млн
-9,74 млн
Net interest expenses
-10,04 млн
-15,66 млн
-9,23 млн
-8,64 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
139,31 млн
190,05 млн
272,71 млн
-69,55 млн
Gain or loss from assets sale
-12,82 млн
-16,31 млн
-
2,30 млн
AI content may include mistakes. Learn more
Google колдонмолору